Treatment of Erdheim-Chester Disease with Long-Term High-Dose Interferon-α
- 1 June 2012
- journal article
- Published by Elsevier in Seminars in Arthritis and Rheumatism
- Vol. 41 (6), 907-913
- https://doi.org/10.1016/j.semarthrit.2011.11.004
Abstract
No abstract availableKeywords
This publication has 35 references indexed in Scilit:
- Pulmonary involvement in Erdheim‐Chester disease: A single‐center study of thirty‐four patients and a review of the literatureArthritis & Rheumatism, 2010
- Imatinib mesylate for platelet-derived growth factor receptor-beta–positive Erdheim-Chester histiocytosisBlood, 2008
- High dose daily interferon-alpha induction and secondary adjunction of ribavirin in treatment-naive patients with chronic hepatitis C: A multicentric, randomised, controlled trialGastroentérologie Clinique Et Biologique, 2006
- Efficacy and tolerance of interferon‐α in the treatment of chronic Hepatitis C in end‐stage renal disease patients on hemodialysisLiver International, 2006
- Improvement of Erdheim?Chester disease in two patients by sequential treatment with vinblastine and mycophenolate mofetilClinical Rheumatology, 2004
- Interferon-ribavirin for chronic hepatitis C with and without cirrhosis: Analysis of individual patient data of six controlled trialsGastroenterology, 1999
- Successful Treatment of Accelerated and Blastic Phase of Chronic Myeloid Leukemia with High-Dose Interferon-alpha Combined with HydroxyureaCancer Detection Prevention, 1998
- Long-term survival in a patient with Rosai-Dorfman disease treated with interferon-αEuropean Journal Of Cancer, 1995
- TREATMENT OF LANGERHANS CELL HISTIOCYTOSIS WITH ALPHA-INTERFERONThe Lancet, 1987
- Über LipoidgranulomatoseVirchows Archiv, 1930